Taro Receives FDA Approval for Levetiracetam Oral Solution

Taro Pharmaceutical Industries Ltd. reported that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Oral Solution, 100 mg/mL ("levetiracetam oral solution").
MSNBC